Biofluid Biopsies 2015

Monday, 16 November 2015 – Tuesday, 17 November 2015

Keynote Speakers

Bob Carter Professor and Chief, University of California-San Diego School of Medicine

Nitzan Rosenfeld Senior Group Leader, CRUK-CI, University of Cambridge and CSO, Inivata Limited

Howard Federoff EVP Health Sciences, Exec Dean, Professor of Neurology, Georgetown University Medical Center

Giacinto Scoles Professor, University of Udine, Italy

David Wong Director, University of California Los Angeles

Kendall Van Keuren-Jensen Associate Professor, Translational Genomics Research Institute

Biofluid Biopsies & High Value Diagnostics 2015 brings together academic researchers, industry researchers, as well as biotechnology and pharmaceutical companies to explore the expanding and evolving field whereby Circulating Biomarkers of various classes are being evaluated for their potential to be developed into diagnostics for cancer as well as other disease classes.

The Biofluid Biopsies Conference Track focuses primarily on blood-based molecular biomarkers, such as circulating tumor DNA (ctDNA) as well as circulating tumor cells (CTCs), and protein-based circulating biomarkers.  There is much interest in the potential of ctDNA for developing biological fluid-based biopsies (such as using plasma, urine, or other biofluids) and the presenters in this track bring together the most up-to-date information and current state-of-the-field.

Major theme of this conference track is to explore the potential of various circulating biomarker classes, such as circulating-free DNA (cfDNA), CTCs, and Extracellular Vesicles (EVs), for Biofluid-based Biopsies and Patient Monitoring.

We also explore the front-end sample preparation challenges and approaches for the deployment of various biofluid classes (plasma, serum, urine, cerebrospinal fluid, ovarian follicular fluid, and saliva) into diagnostics development.

Present Your Research at this Conference in a Poster.  Poster Submission Deadline:  November 2, 2015

(find out more…)